Oncotelic Therapeutics, Inc. - 8-K Filing

Oncotelic presented its PDAOAI platform and HCC research at Drug Discovery 2026 on October 7-8, 2026. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $OTLC

Read the full article at SEC EDGAR

More Regulatory news